Search
Mezigdomide
go.drugbank.com/drugs/DB17584Investigationalunder investigation in clinical trial NCT05372354 (A Study to Evaluate Safety, Drug Levels and Effectiveness of CC-92480 (BMS-986348) in Combination With Other Treatments in Participants With Relapsed or
Buterizine
go.drugbank.com/drugs/DB20973ExperimentalThe usage of the INN stem '-rizine' in the name indicates that Buterizine is a antihistaminic/cerebral (or peripheral) vasodilator. Buterizine has a monoisotopic molecular weight of 466.31 Da.
Lifarizine
go.drugbank.com/drugs/DB20533ExperimentalThe usage of the INN stem '-rizine' in the name indicates that Lifarizine is a antihistaminic/cerebral (or peripheral) vasodilator. Lifarizine has a monoisotopic molecular weight of 436.26 Da.
Diprenorphine
go.drugbank.com/drugs/DB01548IllicitInvestigationalVet approvedA narcotic antagonist similar in action to naloxone. It is used to remobilize animals after etorphine neuroleptanalgesia and is considered a specific antagonist to etorphine. [PubChem]
Categories: Heterocyclic Compounds with 4 or More RingsTagorizine
go.drugbank.com/drugs/DB20098ExperimentalThe usage of the INN stem '-rizine' in the name indicates that Tagorizine is a antihistaminic/cerebral (or peripheral) vasodilator. Tagorizine has a monoisotopic molecular weight of 468.29 Da.
Belarizine
go.drugbank.com/drugs/DB20540ExperimentalThe usage of the INN stem '-rizine' in the name indicates that Belarizine is a antihistaminic/cerebral (or peripheral) vasodilator. Belarizine has a monoisotopic molecular weight of 358.2 Da.
Trelnarizine
go.drugbank.com/drugs/DB21183ExperimentalThe usage of the INN stem '-rizine' in the name indicates that Trelnarizine is a antihistaminic/cerebral (or peripheral) vasodilator. Trelnarizine has a monoisotopic molecular weight of 464.23 Da.
Brodimoprim-4,6-Dicarboxylate
go.drugbank.com/drugs/DB02809ExperimentalThese are organic compounds contaiing a methoxybenzene or a derivative thereof. This medication is known to target the protein dihydrofolate reductase.
TT 173
go.drugbank.com/drugs/DB17717InvestigationalTT 173 is a Modified Human Tissue Factor currently being investigated to treat bleeding disorders such as hemophilia and von Willebrand disease, as well as bleeding episodes in cutaneous injuries or dental